HisiKo (002653.SZ) has received approval for clinical trials of the innovative drug HSK47977 tablets.

China Fortune Financial APP News, Hisun Bio (002653.SZ) announced that the company recently received the "Notice of Approval for Drug Clinical Trials" issued by the National Medical Products Administration, involving the drug: "HSK47977".